Pelago Bioscience AB
Stockholms län
- UEI
- PXCTD3HCRKN4
- CAGE
- AZ5FN
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- Scheeles väg 1, 171 65 Solna, Sweden
- Website
- pelagobio.com
- Founded
- 2013
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Materials
- Chemicals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Proteome-wide cellular thermal shift assay (cetsa) analysis of RR-hydroxynorketamine (RR-HNK). This requisition is for… | Interior Business Center | $30,400 | |
| Pelago bioscience AB:1469771 24-004859 bimn unit requires service contract in order to needed for the development of a… | National Institute on Drug Abuse | $24,900 | |
| Small molecule target deconvolution via cellular thermal shift assay | National Institute on Drug Abuse | $63,800 |
About Pelago Bioscience AB
Pelago Bioscience AB is a for-profit limited liability company based in Solna, Sweden, with a specialized focus on advanced scientific research services, particularly in the realm of molecular and protein analysis. Registered in the System for Award Management (SAM.gov) with an active registration until April 9, 2026, the company operates as a corporate entity with a tax-exempt status. While specific details about the company's broader mission are not provided in the available documentation, the federal contract awards suggest a sophisticated scientific research capability centered on cutting-edge molecular and protein research techniques.
The company has secured multiple federal contract awards from prominent health-related agencies, specifically the National Institutes of Health (NIH), including the National Center for Advancing Translational Sciences (NCATS) and the National Institute on Drug Abuse (NIDA). These contracts, ranging from $24,900 to $63,800, have consistently focused on specialized scientific services such as Cellular Thermal Shift Assay (CETSA) analyses, small molecule target deconvolution, and compound testing. The contracts are primarily purchase orders with no specific set-aside designations, indicating open competition. The scope of work includes complex scientific services like proteome-wide analysis, mass spectrometry protein quantification, sample preparation, and data analysis for pharmaceutical and research purposes. The contracts typically have performance periods ranging from 5 to 12 months, demonstrating Pelago Bioscience AB's capability to execute specialized, time-sensitive scientific research projects for federal agencies.
Quick answers
What is Pelago Bioscience AB's UEI?
Pelago Bioscience AB's Unique Entity ID (UEI) in SAM.gov is PXCTD3HCRKN4.
What is Pelago Bioscience AB's CAGE code?
Pelago Bioscience AB's CAGE code is AZ5FN.
What is Pelago Bioscience AB's primary NAICS code?
Pelago Bioscience AB's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Pelago Bioscience AB located?
Pelago Bioscience AB's physical address in SAM.gov is Scheeles väg 1, 171 65 Solna, Sweden.
Is Pelago Bioscience AB registered in SAM.gov?
Yes. Pelago Bioscience AB's SAM.gov registration is active through March 31, 2027.
What is Pelago Bioscience AB's most recent federal award?
Pelago Bioscience AB's most recent federal contract award is Proteome-wide cellular thermal shift assay (cetsa) analysis of RR-hydroxynorketamine (RR-HNK). This requisition is for… (140D0425P0202), from Interior Business Center, on September 23, 2025.
On GovTribe
See Pelago Bioscience AB's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors